Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1107261 HOUSTON, TX
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$75,362
-$37,657 QoQ
Shares Held
76,900
-31.3% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 60 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. TCRX ranks #100 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in TCRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,362 76,900
2026-03-31 $113,019 111,900
2025-12-31 $115,400 115,400
2025-09-30 $255,528 140,400
2025-06-30 $222,865 153,700
2025-03-31 $156,354 113,300
2024-12-31 $321,936 105,900
2024-09-30 $190,734 38,300
2024-06-30 $224,055 38,300
2024-03-31 $502,602 63,300
2023-12-31 $514,789 88,300
2023-09-30 $226,048 88,300
2023-06-30 $125,000 50,000
2023-03-31 $241,500 115,000
2022-12-31 $178,250 115,000
2022-09-30 $350,750 115,000
2022-06-30 $361,675 115,000
2022-03-31 $322,000 115,000
2021-12-31 $180,000 40,000